OverviewSuggest Edit

AgomAb Therapeutics is a biotherapeutics company developing molecular therapies for the regeneration of damaged tissues. The Company's unique agonistic monoclonal antibody molecules stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.
HQGent, BE


AgomAb is headquartered in
Gent, Belgium

Location Map

Latest Updates

Employees (est.) (Apr 2019)3

Key People/Management at AgomAb

Tim Knotnerus

Tim Knotnerus

Chief Executive Officer
Paolo Michieli

Paolo Michieli

Chief Scientific Officer
Torsten Dreier

Torsten Dreier

Chief Development Officer
Show more

AgomAb Office Locations

AgomAb has an office in Gent
Gent, BE (HQ)
Pieter Van Reysschootlaan 2/104
Show all (1)

AgomAb Financials and Metrics

Summary Metrics

Founding Date


AgomAb total Funding

$23.6 m

AgomAb latest funding size

$23.61 m

Time since last funding

a year ago

AgomAb investors

AgomAb's latest funding round in April 2019 was reported to be $23.6 m. In total, AgomAb has raised $23.6 m
Show all financial metrics

AgomAb Online and Social Media Presence

Embed Graph

AgomAb Frequently Asked Questions

  • When was AgomAb founded?

    AgomAb was founded in 2017.

  • Who are AgomAb key executives?

    AgomAb's key executives are Tim Knotnerus, Paolo Michieli and Torsten Dreier.

  • How many employees does AgomAb have?

    AgomAb has 3 employees.

  • Who are AgomAb competitors?

    Competitors of AgomAb include Calidi Biotherapeutics, Bexion Pharmaceuticals and Cantargia.

  • Where is AgomAb headquarters?

    AgomAb headquarters is located at Pieter Van Reysschootlaan 2/104, Gent.

  • Where are AgomAb offices?

    AgomAb has an office in Gent.

  • How many offices does AgomAb have?

    AgomAb has 1 office.